{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T01:35:41Z","timestamp":1789263341753,"version":"build-2803163510"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Background. Alopecia areata (AA) is an organ-specific autoimmune disease characterized by folliculotropic T-cell infiltrates around anagen-stage hair follicles. The role of T helper (Th)1 and Th2 cytokines in the pathogenesis of AA have not been established.<\/jats:p><jats:p>Aim. To determine whether serum cytokine profiles define the severity of the AA phenotype or are affected by co-existent atopy.<\/jats:p><jats:p>Methods. In total, 17 serum cytokines were measured and compared in 269 patients with AA of varying severity with and without atopy and 18 unrelated controls.<\/jats:p><jats:p>Results. Of the 269 patients with AA, 96% had active disease and 54% were atopic. The disease phenotype was transient patchy AA in 27 patients, persistent patchy AA in 89 and alopecia totalis or alopecia universalis in 153. Levels of Th1, interleukin (IL)-1 receptor antagonist (ra) and IL-8 levels were higher in all patients with AA than in controls. IL-1\u03b1, IL-12 and tumour necrosis factor-\u03b1 levels were higher in patients with AA and atopy than in patients with AA without atopy.<\/jats:p><jats:p>Conclusions. Increased Th1 serum cytokines (IL-2, IL-12 and interferon-\u03b3) and IL-1ra levels are associated with AA regardless of disease severity or the presence of atopy.<\/jats:p>","DOI":"10.1111\/j.1365-2230.2009.03523.x","type":"journal-article","created":{"date-parts":[[2009,10,23]],"date-time":"2009-10-23T14:17:59Z","timestamp":1256307479000},"page":"409-416","source":"Crossref","is-referenced-by-count":58,"title":["Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy"],"prefix":"10.1093","volume":"35","author":[{"given":"N.","family":"Barahmani","sequence":"first","affiliation":[{"name":"Departments of Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lopez","sequence":"additional","affiliation":[{"name":"Biostatistics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Babu","sequence":"additional","affiliation":[{"name":"Departments of Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Biostatistics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. E.","family":"Donley","sequence":"additional","affiliation":[{"name":"Departments of Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Duvic","sequence":"additional","affiliation":[{"name":"Departments of Dermatology"},{"name":"National Alopecia Areata Registry, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,6,1]]},"reference":[{"key":"2023013105383107400_b1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00404628","article-title":"Intrabulbar and peribulbar accumulation of dendritic OKT 6-positive cells in alopecia areata","volume":"276","author":"Wiesner-Menzel","year":"1984","journal-title":"Arch Dermatol Res"},{"key":"2023013105383107400_b2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000085580","article-title":"What can we learn from animal models of alopecia areata?","volume":"211","author":"McElwee","year":"2005","journal-title":"Dermatology"},{"key":"2023013105383107400_b3","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4065\/70.7.628","article-title":"Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989","volume":"70","author":"Safavi","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"2023013105383107400_b4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0733-8635(18)30254-7","article-title":"Topical immunotherapy in the treatment of chronic severe alopecia areata","volume":"11","author":"Shapiro","year":"1993","journal-title":"Dermatol Clin"},{"key":"2023013105383107400_b5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2133.2001.04398.x","article-title":"Impaired responses of peripheral blood mononuclear cells to T-cell stimulants in alopecia areata patients with a poor response to topical immunotherapy","volume":"145","author":"Yoshino","year":"2001","journal-title":"Br J Dermatol"},{"key":"2023013105383107400_b6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/1523-1747.ep12395722","article-title":"Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone","volume":"103","author":"Hoffmann","year":"1994","journal-title":"J Invest Dermatol"},{"key":"2023013105383107400_b7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1521-6616(02)00042-6","article-title":"Transfer of alopecia areata in the human scalp graft\/Prkdc (scid) (SCID) mouse system is characterized by a Th1 response","volume":"106","author":"Gilhar","year":"2003","journal-title":"Clin Immunol"},{"key":"2023013105383107400_b8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000254503","article-title":"A new classification of alopecia areata","volume":"131","author":"Ikeda","year":"1965","journal-title":"Dermatologica"},{"key":"2023013105383107400_b9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.it.2007.05.003","article-title":"The skin barrier, atopic dermatitis and allergy: a role for Langerhans cells?","volume":"28","author":"Callard","year":"2007","journal-title":"Trends Immunol"},{"key":"2023013105383107400_b10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2340\/0001555576421423","article-title":"Cytokines in alopecia areata: contrasting cytokine profiles in localized form and extensive form (alopecia universalis)","volume":"76","author":"Teraki","year":"1996","journal-title":"Acta Derm Venereol"},{"key":"2023013105383107400_b11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1046\/j.1365-2230.2002.01075.x","article-title":"Alopecia areata \u2013 animal models","volume":"27","author":"McElwee","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"2023013105383107400_b12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00403-006-0700-2","article-title":"In vivo levels of IL-4, IL-10, TGF-beta1 and IFN-gamma mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis","volume":"298","author":"Katagiri","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"2023013105383107400_b13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1046\/j.1523-1747.2000.00828.x","article-title":"Role of cytotoxic T cells in chronic alopecia areata","volume":"114","author":"Bodemer","year":"2000","journal-title":"J Invest Dermatol"},{"key":"2023013105383107400_b14","first-page":"33","article-title":"Interferon-gamma in alopecia areata","volume":"14","author":"Arca","year":"2004","journal-title":"Eur J Dermatol"},{"key":"2023013105383107400_b15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1087-0024.2003.00814.x","article-title":"Alopecia areata registry: an overview","volume":"8","author":"Duvic","year":"2003","journal-title":"J Investig Dermatol Symp Proc"},{"key":"2023013105383107400_b16","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2133.2007.07943.x","article-title":"Serum chemokine profiles in patients with alopecia areata","volume":"157","author":"Kuwano","year":"2007","journal-title":"Br J Dermatol"},{"key":"2023013105383107400_b17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000053836","article-title":"Effect of low-dose cyclosporin a microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severe pediatric atopic dermatitis","volume":"125","author":"Bunikowski","year":"2001","journal-title":"Int Arch Allergy Immunol"},{"key":"2023013105383107400_b18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/1523-1747.ep12584215","article-title":"Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts","volume":"107","author":"Konstantinova","year":"1996","journal-title":"J Invest Dermatol"},{"key":"2023013105383107400_b19","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1034\/j.1399-0039.2001.057004318.x","article-title":"Single nucleotide polymorphisms in intron 2 of the human interleukin-1 receptor antagonist (IL-1Ra) gene: further definition of the IL-1 beta and IL-1Ra polymorphisms in North American Caucasians and Taiwanese Chinese","volume":"57","author":"Tseng","year":"2001","journal-title":"Tissue Antigens"},{"key":"2023013105383107400_b20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1601-0825.2006.01285.x","article-title":"Interleukin-1 receptor antagonist gene polymorphism and gingivitis in children","volume":"13","author":"Dashash","year":"2007","journal-title":"Oral Dis"},{"key":"2023013105383107400_b21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000246567","article-title":"Does interleukin-1 induce hair loss?","volume":"191","author":"Hoffmann","year":"1995","journal-title":"Dermatology"},{"key":"2023013105383107400_b22","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.0.CO;2-K","article-title":"IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes","volume":"28","author":"Hurme","year":"1998","journal-title":"Eur J Immunol"},{"key":"2023013105383107400_b23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/1523-1747.ep12395398","article-title":"Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene","volume":"103","author":"Tarlow","year":"1994","journal-title":"J Invest Dermatol"},{"key":"2023013105383107400_b24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.0022-202x.2001.01676.x","article-title":"Interleukin-1 receptor antagonist allele 2 and familial alopecia areata","volume":"118","author":"Barahmani","year":"2002","journal-title":"J Invest Dermatol"},{"key":"2023013105383107400_b25","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0091-6749(99)70088-6","article-title":"Allergen-specific immune deviation from a TH2 to a TH1 response induced by dendritic cells and collagen type I","volume":"104","author":"Brand","year":"1999","journal-title":"J Allergy Clin Immunol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2009.03523.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/35\/4\/409\/48958224\/ced0409.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/35\/4\/409\/48958224\/ced0409.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T07:52:12Z","timestamp":1710661932000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/35\/4\/409\/6622524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,1]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2010,6,1]]},"published-print":{"date-parts":[[2010,6,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2009.03523.x","relation":{},"ISSN":["1365-2230","0307-6938"],"issn-type":[{"value":"1365-2230","type":"electronic"},{"value":"0307-6938","type":"print"}],"subject":[],"published-other":{"date-parts":[[2010,6,1]]},"published":{"date-parts":[[2010,6,1]]}}}